Screening and prostate-cancer mortality in a randomized European study FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ... New England journal of medicine 360 (13), 1320-1328, 2009 | 5384 | 2009 |
MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 2898 | 2018 |
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, M Zappa, V Nelen, ... The Lancet 384 (9959), 2027-2035, 2014 | 1930 | 2014 |
Prostate-cancer mortality at 11 years of follow-up FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, S Ciatto, V Nelen, ... New England Journal of Medicine 366 (11), 981-990, 2012 | 1787 | 2012 |
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 824 | 2018 |
Magnetic resonance imaging–targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided … IG Schoots, MJ Roobol, D Nieboer, CH Bangma, EW Steyerberg, ... European urology 68 (3), 438-450, 2015 | 807 | 2015 |
Reporting and interpreting decision curve analysis: a guide for investigators B Van Calster, L Wynants, JFM Verbeek, JY Verbakel, E Christodoulou, ... European urology 74 (6), 796-804, 2018 | 724 | 2018 |
Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer FJH Drost, DF Osses, D Nieboer, EW Steyerberg, CH Bangma, ... Cochrane Database of Systematic Reviews, 2019 | 641 | 2019 |
Active surveillance for low-risk prostate cancer worldwide: the PRIAS study M Bul, X Zhu, R Valdagni, T Pickles, Y Kakehi, A Rannikko, A Bjartell, ... European urology 63 (4), 597-603, 2013 | 625 | 2013 |
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer J Hugosson, MJ Roobol, M Månsson, TLJ Tammela, M Zappa, V Nelen, ... European urology 76 (1), 43-51, 2019 | 593 | 2019 |
Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program R Raaijmakers, WJ Kirkels, MJ Roobol, MF Wildhagen, FH Schrder Urology 60 (5), 826-830, 2002 | 555 | 2002 |
Quality-of-life effects of prostate-specific antigen screening EAM Heijnsdijk, EM Wever, A Auvinen, J Hugosson, S Ciatto, V Nelen, ... New England Journal of Medicine 367 (7), 595-605, 2012 | 554 | 2012 |
A risk-based strategy improves prostate-specific antigen–driven detection of prostate cancer MJ Roobol, EW Steyerberg, R Kranse, T Wolters, RCN van den Bergh, ... European urology 57 (1), 79-85, 2010 | 413 | 2010 |
Infectious complications and hospital admissions after prostate biopsy in a European randomized trial S Loeb, S van den Heuvel, X Zhu, CH Bangma, FH Schröder, MJ Roobol European urology 61 (6), 1110-1114, 2012 | 390 | 2012 |
A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment LP Bokhorst, R Valdagni, A Rannikko, Y Kakehi, T Pickles, CH Bangma, ... European urology 70 (6), 954-960, 2016 | 387 | 2016 |
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram EW Steyerberg, MJ Roobol, MW Kattan, TH Van der Kwast, HJ De Koning, ... The Journal of urology 177 (1), 107-112, 2007 | 359 | 2007 |
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 354 | 2021 |
Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC) FH Schröder, J Hugosson, S Carlsson, T Tammela, L Määttänen, ... European urology 62 (5), 745-752, 2012 | 347 | 2012 |
Large‐scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal … HJ de Koning, A Auvinen, A Berenguer Sanchez, F Calais da Silva, ... International Journal of Cancer 97 (2), 237-244, 2002 | 344 | 2002 |
Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection FH Jansen, RHN van Schaik, J Kurstjens, W Horninger, H Klocker, ... European urology 57 (6), 921-927, 2010 | 338 | 2010 |